Genetic Determinants Involved in the Susceptibility of Pseudomonas aeruginosa to β-Lactam Antibiotics
- 1 October 2010
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (10), 4159-4167
- https://doi.org/10.1128/aac.00257-10
Abstract
The resistome of P. aeruginosa for three beta-lactam antibiotics, namely, ceftazidime, imipenem, and meropenem, was deciphered by screening a comprehensive PA14 mutant library for mutants with increased or reduced susceptibility to these antimicrobials. Confirmation of the phenotypes of all selected mutants was performed by Etest. Of the total of 78 confirmed mutants, 41 demonstrated a reduced susceptibility phenotype and 37 a supersusceptibility (i.e., altered intrinsic resistance) phenotype, with 6 mutants demonstrating a mixed phenotype, depending on the antibiotic. Only three mutants demonstrated reduced (PA0908) or increased (glnK and ftsK) susceptibility to all three antibiotics. Overall, the mutant profiles of susceptibility suggested distinct mechanisms of action and resistance for the three antibiotics despite their similar structures. More detailed analysis indicated important roles for novel and known beta-lactamase regulatory genes, for genes with likely involvement in barrier function, and for a range of regulators of alginate biosynthesis.Keywords
This publication has 65 references indexed in Scilit:
- Hydrolysis and Inhibition Profiles of β-Lactamases from Molecular Classes A to D with Doripenem, Imipenem, and MeropenemAntimicrobial Agents and Chemotherapy, 2010
- Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance MechanismsClinical Microbiology Reviews, 2009
- Genomewide Identification of Genetic Determinants of Antimicrobial Drug Resistance inPseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2009
- ChronicPseudomonas aeruginosaInfection in Chronic Obstructive Pulmonary DiseaseClinical Infectious Diseases, 2008
- Novel Genetic Determinants of Low-Level Aminoglycoside Resistance in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2008
- Complex Ciprofloxacin Resistome Revealed by Screening a Pseudomonas aeruginosa Mutant Library for Altered SusceptibilityAntimicrobial Agents and Chemotherapy, 2008
- Mutator Genes Giving Rise to Decreased Antibiotic Susceptibility in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2008
- Cumulative Effects of Several Nonenzymatic Mechanisms on the Resistance of Pseudomonas aeruginosa to AminoglycosidesAntimicrobial Agents and Chemotherapy, 2007
- Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsProceedings of the National Academy of Sciences, 2006
- Stepwise Upregulation of thePseudomonas aeruginosaChromosomal Cephalosporinase Conferring High-Level β-Lactam Resistance Involves Three AmpD HomologuesAntimicrobial Agents and Chemotherapy, 2006